Agenda and minutes for the 98th ACAF meeting

Agenda

1. Apologies and announcements 

2. Welcome – Members, Secretariat and Policy colleagues. 

3. Risk Assessment update – Members will receive an update on the work being done by the FSA related to Regulated Products. 

4. Policy update – Members will receive an update on the work being done by the FSA related to Regulated Products. 

5. Minutes from the 97th ACAF meeting – Members will review the minutes from the last meeting and provide comments on any changes needed. ACAF/98/01.

6. Dossier for assessment: RP1605 Titanium dioxide - Members will discuss the paper and carry out a risk assessment of the additive. ACAF/98/02

7. Dossier for assessment: RP2105 Saccharomyces cerevisiae CNCM I-1079 – Members will discuss the application dossier and carry out a risk assessment of the efficacy section. ACAF/98/03.

8. Dossier for assessment: RP2163 – B-Act – Members will discuss the application dossier and carry out a risk assessment of the efficacy section. ACAF/98/04.

9. Dossier for assessment: RP2187 Pediococcus pentosaceus NCIMB 12674 – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/98/05.

10. Dossier for assessment: RP2252 Vitamin B12 (cyanocobalamin) – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/98/06.

11. Response to RFI: RP2071 Enterosure Conc – Members will revisit the applicant’s response to the Committee’s request. ACAF/98/07.

12. Response to RFI: RP2157 Bovacillus® 10 and Bovacillus® WS– Members will revisit the applicant’s response to the Committee’s request.  ACAF/98/08.

13. Draft assessment – RP1696 – Members will evaluate the draft assessment and provide feedback on the content of the document. ACAF/98/09.

14. Any other business  

Upcoming applications 

Date of the next meeting:  24th July 2025 on Microsoft Teams. 

Minutes

coming soon